A PHASE I DOSE ESCALATION STUDY OF TOPICAL BEXAROTENE IN WOMEN AT HIGH RISK FOR BREAST CANCER

NIH RePORTER · NIH · N01 · $106,072 · view on reporter.nih.gov ↗

Abstract

The proposed clinical trial will evaluate safety and toxicity of topical bexarotene 1% gel to the breast in healthy women at high risk for breast cancer and bexarotene concentration in the breast tissue.

Key facts

NIH application ID
10251826
Project number
261201200034I-P00005-26100012-1
Recipient
UNIVERSITY OF TX MD ANDERSON CAN CTR
Principal Investigator
POWEL BROWN
Activity code
N01
Funding institute
NIH
Fiscal year
2020
Award amount
$106,072
Award type
—
Project period
2017-09-01 → 2021-07-31